Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sana Biotechnology, Inc. | 8,615,337 | reported | 13 Sept 2023 | tx 14+34,239,018−46,020,293 |
| Seres Therapeutics, Inc. | 3,258,134 | reported | 23 Nov 2020 | tx 6−7,907,179 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 2,825,989 | — | |
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 70,813 | — | |
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 4,926,378 | — | |
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 1,181,745 | — | |
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 2,431,281 | — | |
| 13 Sept 2023 | OTHER | Sana Biotechnology, Inc. | 345,069 | — | |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 11,585,199 | — | |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 11,441,326 | — | |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 9,725,122 | — | |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 1,487,371 | — | |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 1,487,371 | 0.00 USD | deriv |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 11,441,326 | 0.00 USD | deriv |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 11,585,199 | 0.00 USD | deriv |
| 08 Feb 2021 | CONVERSION | Sana Biotechnology, Inc. | 9,725,122 | 0.00 USD | deriv |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 43,154 | 0.00 USD | |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 1,481,481 | 0.00 USD | |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 1,186,310 | 0.00 USD | |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 966,234 | 0.00 USD | |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 642,180 | 0.00 USD | |
| 23 Nov 2020 | OTHER | Seres Therapeutics, Inc. | 3,587,820 | 0.00 USD |